| abstract |
The present invention provides a benzoate salt of Formula (I), is also known as 4-(5-methyloxazolo[4,5-b]pyridine-2-yl)-1 ,4- diazabicyclo[3.2.2]nonane. The benzoate salt of the invention is useful in the treatment of schizophrenia and Alzheimer's Disease. It is particularly of use in the treatment of cognitive deficits associated with schizophrenia, cognitive and attention deficit symptoms of Alzheimer's Disease, and neurodegeneration associated with Alzheimer's Disease. |